Schrödinger develops physics-based computational chemistry software used by pharmaceutical companies and materials scientists to predict molecular properties and accelerate drug design through simulation rather than trial-and-error experimentation. The company's platform combines quantum mechanics, molecular dynamics, and machine learning to model how drug candidates interact with biological targets at atomic resolution. Engineering challenges include optimizing compute-intensive simulations across large GPU clusters, developing force field parameters that balance accuracy with computational tractability, and building intuitive interfaces for complex scientific workflows. Their hiring patterns reflect growing industry adoption of computational approaches to drug discovery, with demand for engineers skilled in scientific computing, high-performance distributed systems, and the intersection of physics-based and data-driven modeling.
| Location | Listings |
|---|